Omega 3 Supplements Market Share, Size, Trends, Industry Analysis Report, By Form (Tablets, Capsules, Soft Gels), By Functionality (Cardiovascular Health, Brain, Nervous System & Mental Health, Eye Diseases, Diabetes), By End-Use; By Source; By Regions; Segment Forecast, 2021 - 2028

报告摘要

The global omega 3 supplements market was valued at USD 5.57 billion in 2020 and is expected to grow at a CAGR of 8.6% during the forecast period. Rising cases of lifestyle-borne sedentary chronic conditions such as cancer, stroke, coronary heart disease, and arthritis are the key driver for the market for omega 3 supplements.

了解有关此报告的更多信息:request for sample pages

Omega 3脂肪酸对生长和身体发育至关重要。众所周知，这些药物可以降低心脏相关疾病的风险，如心跳和心律失常，甚至可能导致猝死。它还有助于降低甘油三酯水平，从而减缓动脉粥样硬化斑块的形成速度，降低血压波动。

欧米茄3补充市场报告范围

欧米茄3补充剂的市场主要根据来源、形式、功能、最终用途和地理区域进行细分。

By Source	按形式	By Functionality	按最终用途	按地区
鱼油 磷虾油 海藻油 Others	平板 Capsules 软凝胶 Others	心血管健康 Brain, Nervous System & Mental Health 眼病 糖尿病 Others	Adults 老年病 孕妇 Children 婴儿	北美（美国、加拿大） 欧洲（法国、德国、英国、意大利、西班牙、荷兰、奥地利） Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) 拉丁美洲（巴西、墨西哥、阿根廷） 中东和非洲（沙特阿拉伯、阿联酋、以色列、南非）

了解有关此报告的更多信息:request for sample pages

Insight by Source

The fish oil market segment of the omega 3 supplements accounted to hold the largest share in the global market, in 2020. Fish oil is one of the traditional sources of omega 3 fatty acids. COD liver oil derived from fish is mostly used to treat joint pains and is good for vision. Different types of fishes are an important source of vitamins and other essential nutrients also facilitating the segment’s market growth.

However, the algae-based segment is anticipated to register a lucrative growth rate over the assessment period. The growing consumer inclination towards natural, plant-derived alternatives and growing vegan population are largely responsible for such high growth. There are different algae-based膳食补充剂已经在市场上提供，如软凝胶，胶，小球藻，胶囊，螺旋藻。

Insight by Functionality

心血管健康部门在2020年的收入份额最大。欧米茄3补充剂有助于预防心血管疾病，稳定心跳，降低坏胆固醇，维持血压。所有这些好处预计将推动该部门的增长欧米茄3补充剂。

根据美国心脏协会的估计，2017年，全世界有超过17.3人患有心脏相关疾病。居住在美国、法国、英国和西班牙等发达国家的人胆固醇和血压都很高。这导致了对欧米伽3高等级保健补充剂的需求。

然而，欧米茄3补充剂的神经系统细分市场预计将在研究期间见证利润丰厚的市场增长率。据世界卫生组织估计，全球约有5000万人患有癫痫症。此外，截至2017年，仅在美国，大萧条就影响了322多个国家。

此外,在过去的几年里,人们的数量suffering from epilepsy increased in the U.S. For instance, according to a study published by the CDC, around 3 million people were suffering from epilepsy. The Anxiety and Depression Association in America reported that each year, there is over 18.1 percent of the total U.S population suffers from anxiety. The prevalence of mental disorders in the country has anticipated the demand for omega 3 supplements.

地理概况

North America omega 3 supplements market is the largest revenue contributor to the global market and holding a major market share of omega 3 supplements. The region comprises a vast population suffering from obesity and other lifestyle-related diseases, which were primarily due to changing dietary needs and habits due to processed and ready-to-eat foods, hampering an individual’s heath. The evolution of supplements and other functional foods can provide several health benefits, apart from nutrition.

根据纽约州政府的研究，到2020年，该州每年约有61万人死于心脏相关疾病。欧米茄3补充剂对市场上的一些男性和女性的心脏相关疾病特别有用。因此，这种具有增强营养价值的膳食补充剂有望补充该地区欧米茄3补充剂的增长。

亚太欧米茄3补充剂市场预计将见证一个有利可图的增长率在研究期间。这主要是由于保健品支出的增加、消费者意识的提高以及该地区健身中心的增加。此外，不断增长的老年人口、不断上升的医疗保健成本以及跨国公司在扩大分销网络方面的强烈关注，也有利于欧米茄3补充剂在该地区的市场增长。yabo娱乐vip

Moreover, in a country like India, there is a continuous evolution of lifestyles as adopted by western countries, which has resulted in lifestyle-borne conditions such as obesity, diabetes, and other heart-related ailments. Thus, urban populations with high disposable income are opting for such dietary supplements to avoid the occurrence of any kind such diseases.

竞争洞察力

Some of the key market players operating in the global omega 3 supplements industry comprises Nordic Naturals, Inc., Reckitt Benckiser Group plc, NutriGold Inc., Pharma Nord B.V, NOW Foods, Vital Choice Wild Seafood & Organics, Aker BioMarine AS, Pharmavite LLC, i-Health, Inc., KD Pharma Group, GlaxoSmithKline plc, Natrol LLC, OmegaBrite, Optimum Nutrition, Inc., Carlson Laboratories, VAYA Pharma, SPC, Bionova, The Nature's Bounty Co., and Arkopharma.